OrbiMed Capital GP V LLC's Net Worth

$1.23 Billion

Estimate Recalculated Feb 21, 2024 07:10PM EST

Who is OrbiMed Capital GP V LLC?

OrbiMed Capital GP V LLC has an estimated net worth of $1.23 Billion. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., RHYTHM PHARMACEUTICALS, INC., PMV Pharmaceuticals, Inc., SI-BONE, Inc., Intellia Therapeutics, Inc., Inspire Medical Systems, Inc., Aerpio Pharmaceuticals, Inc., Tricida, Inc., Adaptimmune Therapeutics PLC, ARMO BioSciences, Inc., Loxo Oncology, Inc., Nabriva Therapeutics AG, Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Compass Therapeutics, Inc., and Corvus Pharmaceuticals, Inc..

SEC CIK

OrbiMed Capital GP V LLC's CIK is 0001615374

Past Insider Trading and Trends

2016 was OrbiMed Capital GP V LLC's most active year for acquiring shares with 20 total transactions. OrbiMed Capital GP V LLC's most active month to acquire stocks was the month of April. 2018 was OrbiMed Capital GP V LLC's most active year for disposing of shares, totalling 29 transactions. OrbiMed Capital GP V LLC's most active month to dispose stocks was the month of October. 2021 saw OrbiMed Capital GP V LLC paying a total of $37,066,528.50 for 8,714,825 shares, this is the most they've acquired in one year. In 2018 OrbiMed Capital GP V LLC cashed out on 65,686,567 shares for a total of $248,478,616.31, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.96

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.71%
-19.58K
$30.43
-$595,768.40
2.75M
May 22
Form 4
-4.54%
-131.64K
$30.88
-$4,065,439.72
2.77M
May 18 - May 21
Form 4
2.9M
$17.00
2.9M
Oct 10
Form 3
0
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.095

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.66M
$18.00
2.66M
May 11
Form 3
0
0
No matching records found

Aerpio Pharmaceuticals, Inc. (AADI) Snapshot price: $1.755

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
$1.46
-$21,400.00
0
Dec 8
Form 4
+17.60%
777.5K
$3.85
$2,993,375.00
5.19M
Jun 28
Form 4
+20.88%
763K
$5.00
$3,814,975.00
4.42M
Mar 15
Form 3
0
0
No matching records found

Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.275

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.38%
-18.70K
$13.56
-$253,631.00
4.9M
Jun 4 - Jun 6
Form 4
-3.36%
-171.00K
$13.51
-$2,310,420.00
4.92M
May 30 - Jun 1
Form 4
-0.20%
-10.30K
$13.50
-$139,050.00
5.09M
May 14
Form 4
-17.04%
-1.05M
$11.50
-$12,053,729.99
5.1M
Mar 27 - Mar 29
Form 4
+24.01%
1.19M
$4.20
$4,999,999.20
6.15M
Mar 27
Form 4
+6.11%
1.71M
$10.42
$17,849,568.00
29.75M
May 20 - May 24
Form 3
0
0
No matching records found

Loxo Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.99%
-250.00K
$82.50
-$20,625,000.00
941K
Dec 8
Form 4
-18.31%
-267.00K
$75.00
-$20,025,000.00
1.19M
Nov 22
Form 4
-15.63%
-270.00K
$74.26
-$20,051,388.82
1.46M
Nov 16
Form 4
-20.58%
-447.86K
$26.96
-$12,074,224.72
1.73M
Aug 10
Form 4
2.18M
$13.00
2.18M
Aug 6
Form 3
0
0
No matching records found